Masimo Corporation (MASI)
| Market Cap | 7.61B |
| Revenue (ttm) | 2.18B |
| Net Income (ttm) | -569.40M |
| Shares Out | 53.71M |
| EPS (ttm) | -10.55 |
| PE Ratio | n/a |
| Forward PE | 24.75 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 840,733 |
| Open | 142.82 |
| Previous Close | 142.26 |
| Day's Range | 140.83 - 147.82 |
| 52-Week Range | 133.70 - 194.88 |
| Beta | 1.26 |
| Analysts | Buy |
| Price Target | 188.80 (+33.26%) |
| Earnings Date | Nov 4, 2025 |
About MASI
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for MASI stock is "Buy." The 12-month stock price target is $188.8, which is an increase of 33.26% from the latest price.
News
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is invest...
Masimo Pitches 2028 Plan With 30% Operating Margins
Masimo Corp (NASDAQ: MASI) on Wednesday hosted its 2025 Investor Day. At the event, Masimo's management team provided an update on the company's long-term strategy.
Masimo Corporation (MASI) Analyst/Investor Day Transcript
Masimo Corporation (MASI) Analyst/Investor Day Transcript
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company's headquarters. At the event, Masimo's management team provided an update on the Company's long...
Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case
IRVINE, Calif. , Nov. 18, 2025 /PRNewswire/ -- A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo's patented heart monito...
DRC Congratulates Knobbe Martens on its $634 Million Win for Masimo
DRC congratulates Knobbe Martens on a decisive jury verdict awarding its client Masimo more than $634 million in an Apple Watch patent infringement case.
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares
Sold 45,000 shares in Masimo, reducing reported position by $7,569,900 Transaction represents a 4.0301% change in 13F reportable assets under management (AUM) Post-trade stake: 0 shares, $0 reported v...
Jury says Apple owes Masimo $634M for patent infringement
A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen monitoring technology.
US jury says Apple must pay Masimo $634 million in smartwatch patent case
A federal jury in California said on Friday that Apple owes medical-monitoring technology company Masimo $634 million for infringing a patent covering blood-oxygen reading technology.
Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today issued the following statement in response to the jury verdict announced in the U.S. District Court for the Central District of California,...
Masimo Corporation (MASI) Q3 2025 Earnings Call Transcript
Masimo Corporation ( MASI) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Eli Kammerman - Vice President of Business Development & Investor Relations Catherine Szyman - CEO &...
Masimo Reports Third Quarter 2025 Results
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter ended September 27, 2025. Third Quarter 2025 Results From Continuing Oper...
Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Masimo Corporation (NASDAQ: MASI) breached their fiduciary duties t...
Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2025 financial results for the period ended September 27, 2025, after the market closes on Tuesday, November 4, 2025. ...
Masimo to Host Investor Day on December 3, 2025
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced it will host a meeting with the analyst and investor community at 9:00am PT on Wednesday, December 3, 2025. Presentations will be...
In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--A feasibility study for a large real-world trial found Masimo SET® pulse oximetry performed accurately on critically ill patients of all skin tones.
Masimo Completes Sale of Consumer Audio Business to HARMAN International
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced it has completed the previously announced sale of its Sound United consumer audio business to HARMAN International (“HARMAN”), a ...
HARMAN Completes Sound United Acquisition to Expand Premium Audio Leadership
STAMFORD, Conn.--(BUSINESS WIRE)--HARMAN International ("HARMAN"), a wholly-owned subsidiary of Samsung Electronics Co., Ltd., focused on connected technologies for automotive, consumer, and enterpris...
New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--A new study showed that universal surveillance monitoring with Masimo SET® pulse oximetry and Patient SafetyNet™ can yield significant cost savings.
Masimo Announces Expansion of Strategic Partnership with Philips
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE: PHG, AEX: PHIA). Building on over two d...
Masimo Corporation (MASI) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Masimo Corporation (NASDAQ:MASI) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 1:30 PM EDT Company Participants Micah Young - Chief Financial Officer Catherine Szyman - CEO & D...
Masimo to Present in the Wells Fargo Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, Sept 4, 2025 at 1:30 p.m. Eastern time...
Masimo sues US Customs over approval of Apple Watch imports
Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading tec...
Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient populations.
Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025
We added key positions in Masimo, Exact Sciences, Eli Lilly, Penumbra, and Edwards Lifesciences, each with strong growth drivers and market leadership. Our investment in Masimo is supported by divesti...